LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 10 of total 101

Search options

  1. Article ; Online: We asked the experts: Normalize challenges, build community, and develop mentorship: A guide for proactive institutional support for child rearing during surgical training.

    Colley, Alexis / Yap, Ava / Trang, Karen / Kornblith, Lucy Z / Varma, Madhulika G / Vu, Lan

    World journal of surgery

    2024  Volume 48, Issue 3, Page(s) 524–526

    MeSH term(s) Humans ; Child ; Mentors ; Child Rearing ; Surveys and Questionnaires
    Language English
    Publishing date 2024-02-16
    Publishing country United States
    Document type Editorial
    ZDB-ID 224043-9
    ISSN 1432-2323 ; 0364-2313
    ISSN (online) 1432-2323
    ISSN 0364-2313
    DOI 10.1002/wjs.12095
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  2. Article ; Online: The intersection of coagulation activation and inflammation after injury: What you need to know.

    Costantini, Todd W / Kornblith, Lucy Z / Pritts, Timothy / Coimbra, Raul

    The journal of trauma and acute care surgery

    2023  Volume 96, Issue 3, Page(s) 347–356

    MeSH term(s) Humans ; Blood Coagulation ; Inflammation
    Language English
    Publishing date 2023-11-13
    Publishing country United States
    Document type Journal Article
    ZDB-ID 2651070-4
    ISSN 2163-0763 ; 2163-0755
    ISSN (online) 2163-0763
    ISSN 2163-0755
    DOI 10.1097/TA.0000000000004190
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  3. Article ; Online: "Importance of catecholamine signaling in the development of platelet exhaustion after traumatic injury": Reply.

    Matthay, Zachary A / Fields, Alexander T / Kornblith, Lucy Z

    Journal of thrombosis and haemostasis : JTH

    2022  Volume 20, Issue 11, Page(s) 2717–2718

    MeSH term(s) Humans ; Catecholamines ; Blood Platelets ; Platelet Aggregation Inhibitors
    Chemical Substances Catecholamines ; Platelet Aggregation Inhibitors
    Language English
    Publishing date 2022-10-12
    Publishing country England
    Document type Letter ; Comment
    ZDB-ID 2112661-6
    ISSN 1538-7836 ; 1538-7933
    ISSN (online) 1538-7836
    ISSN 1538-7933
    DOI 10.1111/jth.15869
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  4. Article ; Online: Response to Letter to the Editor submitted by Dr. Gando and Dr. Otomo re: Trauma-induced coagulopathy: The past, present, and future.

    Kornblith, Lucy Z / Moore, Hunter B / Cohen, Mitchell J

    Journal of thrombosis and haemostasis : JTH

    2019  Volume 17, Issue 9, Page(s) 1569–1571

    MeSH term(s) Blood Coagulation Disorders ; Humans ; Wounds and Injuries
    Language English
    Publishing date 2019-08-29
    Publishing country England
    Document type Letter ; Comment
    ZDB-ID 2112661-6
    ISSN 1538-7836 ; 1538-7933
    ISSN (online) 1538-7836
    ISSN 1538-7933
    DOI 10.1111/jth.14533
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  5. Article ; Online: Response to Letter to the Editor submitted by Dr. Wada and Dr. Yamakawa re: Trauma-induced coagulopathy: The past, present, and future.

    Kornblith, Lucy Z / Moore, Hunter B / Cohen, Mitchell J

    Journal of thrombosis and haemostasis : JTH

    2019  Volume 17, Issue 9, Page(s) 1574–1576

    MeSH term(s) Blood Coagulation Disorders ; Humans ; Wounds and Injuries
    Language English
    Publishing date 2019-09-05
    Publishing country England
    Document type Letter ; Comment
    ZDB-ID 2112661-6
    ISSN 1538-7836 ; 1538-7933
    ISSN (online) 1538-7836
    ISSN 1538-7933
    DOI 10.1111/jth.14581
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  6. Article ; Online: Trauma-induced coagulopathy: The past, present, and future.

    Kornblith, Lucy Z / Moore, Hunter B / Cohen, Mitchell J

    Journal of thrombosis and haemostasis : JTH

    2019  Volume 17, Issue 6, Page(s) 852–862

    Abstract: Trauma remains a leading cause of death worldwide, and most early preventable deaths in both the civilian and military settings are due to uncontrolled hemorrhage, despite paradigm advances in modern trauma care. Combined tissue injury and shock result ... ...

    Abstract Trauma remains a leading cause of death worldwide, and most early preventable deaths in both the civilian and military settings are due to uncontrolled hemorrhage, despite paradigm advances in modern trauma care. Combined tissue injury and shock result in hemostatic failure, which has been identified as a multidimensional molecular, physiologic and clinical disorder termed trauma-induced coagulopathy (TIC). Understanding the biology of TIC is of utmost importance, as it is often responsible for uncontrolled bleeding, organ failure, thromboembolic complications, and death. Investigations have shown that TIC is characterized by multiple phenotypes of impaired hemostasis due to altered biology in clot formation and breakdown. These coagulopathies are attributable to tissue injury and shock, and encompass underlying endothelial, immune and inflammatory perturbations. Despite the recognition and identification of multiple mechanisms and mediators of TIC, and the development of targeted treatments, the mortality rates and associated morbidities due to hemorrhage after injury remain high. The purpose of this review is to examine the past and present understanding of the multiple distinct but highly integrated pathways implicated in TIC, in order to highlight the current knowledge gaps and future needs in this evolving field, with the aim of reducing morbidity and mortality after injury.
    MeSH term(s) Blood Coagulation Disorders/blood ; Blood Coagulation Disorders/etiology ; Blood Coagulation Factors/metabolism ; Blood Platelets/physiology ; Endothelium/metabolism ; Exsanguination/blood ; Exsanguination/etiology ; Fibrinolysis ; Hemorrhage/blood ; Hemorrhage/etiology ; Hemostasis ; Humans ; Protein C/metabolism ; Shock, Hemorrhagic/blood ; Shock, Hemorrhagic/etiology ; Wounds and Injuries/blood ; Wounds and Injuries/complications
    Chemical Substances Blood Coagulation Factors ; Protein C
    Language English
    Publishing date 2019-05-13
    Publishing country England
    Document type Journal Article ; Research Support, N.I.H., Extramural ; Research Support, Non-U.S. Gov't ; Research Support, U.S. Gov't, Non-P.H.S. ; Review
    ZDB-ID 2112661-6
    ISSN 1538-7836 ; 1538-7933
    ISSN (online) 1538-7836
    ISSN 1538-7933
    DOI 10.1111/jth.14450
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  7. Article ; Online: Regarding γ' fibrinogen levels as a biomarker of COVID-19 respiratory disease severity.

    Kornblith, Lucy Z / Sadhanandhan, Bindhya / Arun, Sreepriya / Long, Rebecca / Johnson, Alicia J / Noll, Jamie / Ramchand, C N / Olynyk, John K / Farrell, David H

    Blood cells, molecules & diseases

    2024  Volume 105, Page(s) 102825

    MeSH term(s) Humans ; Fibrinogen ; COVID-19/diagnosis ; Biomarkers ; Risk Factors ; Blood Coagulation Tests
    Chemical Substances Fibrinogen (9001-32-5) ; Biomarkers
    Language English
    Publishing date 2024-01-12
    Publishing country United States
    Document type Letter ; Comment
    ZDB-ID 1237083-6
    ISSN 1096-0961 ; 1079-9796
    ISSN (online) 1096-0961
    ISSN 1079-9796
    DOI 10.1016/j.bcmd.2024.102825
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  8. Article ; Online: A comparison of computational algorithms for the Bayesian analysis of clinical trials.

    Chen, Ziming / Berger, Jeffrey S / Castellucci, Lana A / Farkouh, Michael / Goligher, Ewan C / Hade, Erinn M / Hunt, Beverley J / Kornblith, Lucy Z / Laweler, Patrick R / Leifer, Eric S / Lorenzi, Elizabeth / Neal, Matthew D / Zarychanski, Ryan / Heath, Anna

    Clinical trials (London, England)

    2024  , Page(s) 17407745241247334

    Abstract: Background: Clinical trials are increasingly using Bayesian methods for their design and analysis. Inference in Bayesian trials typically uses simulation-based approaches such as Markov Chain Monte Carlo methods. Markov Chain Monte Carlo has high ... ...

    Abstract Background: Clinical trials are increasingly using Bayesian methods for their design and analysis. Inference in Bayesian trials typically uses simulation-based approaches such as Markov Chain Monte Carlo methods. Markov Chain Monte Carlo has high computational cost and can be complex to implement. The Integrated Nested Laplace Approximations algorithm provides approximate Bayesian inference without the need for computationally complex simulations, making it more efficient than Markov Chain Monte Carlo. The practical properties of Integrated Nested Laplace Approximations compared to Markov Chain Monte Carlo have not been considered for clinical trials. Using data from a published clinical trial, we aim to investigate whether Integrated Nested Laplace Approximations is a feasible and accurate alternative to Markov Chain Monte Carlo and provide practical guidance for trialists interested in Bayesian trial design.
    Methods: Data from an international Bayesian multi-platform adaptive trial that compared therapeutic-dose anticoagulation with heparin to usual care in non-critically ill patients hospitalized for COVID-19 were used to fit Bayesian hierarchical generalized mixed models. Integrated Nested Laplace Approximations was compared to two Markov Chain Monte Carlo algorithms, implemented in the software JAGS and stan, using packages available in the statistical software R. Seven outcomes were analysed: organ-support free days (an ordinal outcome), five binary outcomes related to survival and length of hospital stay, and a time-to-event outcome. The posterior distributions for the treatment and sex effects and the variances for the hierarchical effects of age, site and time period were obtained. We summarized these posteriors by calculating the mean, standard deviations and the 95% equitailed credible intervals and presenting the results graphically. The computation time for each algorithm was recorded.
    Results: The average overlap of the 95% credible interval for the treatment and sex effects estimated using Integrated Nested Laplace Approximations was 96% and 97.6% compared with stan, respectively. The graphical posterior densities for these effects overlapped for all three algorithms. The posterior mean for the variance of the hierarchical effects of age, site and time estimated using Integrated Nested Laplace Approximations are within the 95% credible interval estimated using Markov Chain Monte Carlo but the average overlap of the credible interval is lower, 77%, 85.6% and 91.3%, respectively, for Integrated Nested Laplace Approximations compared to stan. Integrated Nested Laplace Approximations and stan were easily implemented in clear, well-established packages in R, while JAGS required the direct specification of the model. Integrated Nested Laplace Approximations was between 85 and 269 times faster than stan and 26 and 1852 times faster than JAGS.
    Conclusion: Integrated Nested Laplace Approximations could reduce the computational complexity of Bayesian analysis in clinical trials as it is easy to implement in R, substantially faster than Markov Chain Monte Carlo methods implemented in JAGS and stan, and provides near identical approximations to the posterior distributions for the treatment effect. Integrated Nested Laplace Approximations was less accurate when estimating the posterior distribution for the variance of hierarchical effects, particularly for the proportional odds model, and future work should determine if the Integrated Nested Laplace Approximations algorithm can be adjusted to improve this estimation.
    Language English
    Publishing date 2024-05-16
    Publishing country England
    Document type Journal Article
    ZDB-ID 2138796-5
    ISSN 1740-7753 ; 1740-7745
    ISSN (online) 1740-7753
    ISSN 1740-7745
    DOI 10.1177/17407745241247334
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  9. Article ; Online: Effects of inflammation on thrombosis and outcomes in COVID-19: secondary analysis of the ATTACC/ACTIV-4a trial.

    Walborn, Amanda T / Heath, Anna / Neal, Matthew D / Zarychanski, Ryan / Kornblith, Lucy Z / Hunt, Beverley J / Castellucci, Lana A / Hochman, Judith S / Lawler, Patrick R / Paul, Jonathan D

    Research and practice in thrombosis and haemostasis

    2023  Volume 7, Issue 7, Page(s) 102203

    Abstract: Background: Patients hospitalized for COVID-19 are at high risk of thrombotic complications and organ failure, and often exhibit severe inflammation, which may contribute to hypercoagulability.: Objectives: To determine whether patients hospitalized ... ...

    Abstract Background: Patients hospitalized for COVID-19 are at high risk of thrombotic complications and organ failure, and often exhibit severe inflammation, which may contribute to hypercoagulability.
    Objectives: To determine whether patients hospitalized for COVID-19 experience differing frequencies of thrombotic and organ failure complications and derive variable benefits from therapeutic-dose heparin dependent on the extent of systemic inflammation and whether observed benefit from therapeutic-dose anticoagulation varies depending on the degree of systemic inflammation.
    Methods: We analyzed data from 1346 patients hospitalized for COVID-19 enrolled in the ATTACC and ACTIV-4a platforms who were randomized to therapeutic-dose heparin or usual care for whom levels of C-reactive protein (CRP) were reported at baseline.
    Results: Increased CRP was associated with worse patient outcomes, including a >98% posterior probability of increased organ support requirement, hospital length of stay, risk of 28-day mortality, and incidence of major thrombotic events or death (patients with CRP 40-100 mg/L or ≥100 mg/L compared to patients with CRP <40 mg/L). Patients with CRP 40 to 100 mg/L experienced the greatest degree of benefit from treatment with therapeutic doses of unfractionated or low molecular weight heparin compared with usual-care prophylactic doses. This was most significant for an increase in organ support-free days (odds ratio: 1.63; 95% confidence interval, 1.09-2.40; 97.9% posterior probability of beneficial effect), with trends toward benefit for other evaluated outcomes.
    Conclusion: Moderately ill patients hospitalized for COVID-19 with CRP between 40 mg/L and 100 mg/L derived the greatest benefit from treatment with therapeutic-dose heparin.
    Language English
    Publishing date 2023-09-16
    Publishing country United States
    Document type Journal Article
    ISSN 2475-0379
    ISSN (online) 2475-0379
    DOI 10.1016/j.rpth.2023.102203
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  10. Article ; Online: Association of SARS-CoV-2 nucleocapsid viral antigen and the receptor for advanced glycation end products with development of severe disease in patients presenting to the emergency department with COVID-19.

    Matthay, Zachary A / Fields, Alexander T / Wick, Katherine D / Jones, Chayse / Lane, H Clifford / Herrera, Kimberly / Nuñez-Garcia, Brenda / Gennatas, Efstathios / Hendrickson, Carolyn M / Kornblith, Aaron E / Matthay, Michael A / Kornblith, Lucy Z

    Frontiers in immunology

    2023  Volume 14, Page(s) 1130821

    Abstract: Introduction: There remains a need to better identify patients at highest risk for developing severe Coronavirus Disease 2019 (COVID-19) as additional waves of the pandemic continue to impact hospital systems. We sought to characterize the association ... ...

    Abstract Introduction: There remains a need to better identify patients at highest risk for developing severe Coronavirus Disease 2019 (COVID-19) as additional waves of the pandemic continue to impact hospital systems. We sought to characterize the association of receptor for advanced glycation end products (RAGE), SARS-CoV-2 nucleocapsid viral antigen, and a panel of thromboinflammatory biomarkers with development of severe disease in patients presenting to the emergency department with symptomatic COVID-19.
    Methods: Blood samples were collected on arrival from 77 patients with symptomatic COVID-19, and plasma levels of thromboinflammatory biomarkers were measured.
    Results: Differences in biomarkers between those who did and did not develop severe disease or death 7 days after presentation were analyzed. After adjustment for multiple comparisons, RAGE, SARS-CoV-2 nucleocapsid viral antigen, interleukin (IL)-6, IL-10 and tumor necrosis factor receptor (TNFR)-1 were significantly elevated in the group who developed severe disease (all
    Discussion: Elevated RAGE and SARS-CoV-2 nucleocapsid viral antigen on emergency department presentation are strongly associated with development of severe disease at 7 days. These findings are of clinical relevance for patient prognostication and triage as hospital systems continue to be overwhelmed. Further studies are warranted to determine the feasibility and utility of point-of care measurements of these biomarkers in the emergency department setting to improve patient prognostication and triage.
    MeSH term(s) Humans ; COVID-19 ; SARS-CoV-2 ; Receptor for Advanced Glycation End Products ; Nucleocapsid ; Antigens ; Biomarkers ; Antigens, Viral
    Chemical Substances Receptor for Advanced Glycation End Products ; Antigens ; Biomarkers ; Antigens, Viral
    Language English
    Publishing date 2023-03-21
    Publishing country Switzerland
    Document type Journal Article ; Research Support, N.I.H., Extramural
    ZDB-ID 2606827-8
    ISSN 1664-3224 ; 1664-3224
    ISSN (online) 1664-3224
    ISSN 1664-3224
    DOI 10.3389/fimmu.2023.1130821
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

To top